Evidence map›Paper›PMID 36582805›Full record

ArticleFrontiers in oncology2022

Left versus right approach for middle and lower esophageal squamous cell carcinoma: A propensity score-matched study.

Xining Zhang, Kang Qi, Weiming Huang, Jingwei Liu, Gang Lin, Jian Li

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Xining ZhangDepartment of Thoracic Surgery, Peking University Health Science Center, Peking University First Hospital, Beijing, China.
Kang QiDepartment of Thoracic Surgery, Peking University Health Science Center, Peking University First Hospital, Beijing, China.
Weiming HuangDepartment of Thoracic Surgery, Peking University Health Science Center, Peking University First Hospital, Beijing, China.
Jingwei LiuDepartment of Thoracic Surgery, Peking University Health Science Center, Peking University First Hospital, Beijing, China.
Gang LinDepartment of Thoracic Surgery, Peking University Health Science Center, Peking University First Hospital, Beijing, China.
Jian LiDepartment of Thoracic Surgery, Peking University Health Science Center, Peking University First Hospital, Beijing, China.
Peking University · CNPeking University First Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Despite superior short-term outcomes, there is considerable debate about the oncological efficacy of the left approach esophagectomy for middle and lower squamous esophageal carcinoma (ESCC). A propensity score-matched retrospective study was conducted to evaluate the left approach's short- and long-term effects. Methods: We recorded data from patients with ESCC who underwent curative resection Results: One hundred and forty-eight ESCC patients underwent esophagectomy Conclusions: The left approach esophagectomy might facilitate postoperative recovery in patients with middle and lower ESCC. With adequate lymphadenectomy, the left approach esophagectomy might achieve similar long-term outcomes for middle and lower ESCC patients.

Indexed as

esophageal squamous cell carcinomaIvor-Lewis procedurelymphadenectomyMcKeown procedureSweet procedure

Identifiers

PMID36582805
PMCPMC9792602
OpenAlexW4311354348

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.